Economic Evaluation of Cataract: A Systematic Mapping Review.
And cost–utility analysis
Cataract
Cost-effectiveness analysis
Journal
Ophthalmology and therapy
ISSN: 2193-8245
Titre abrégé: Ophthalmol Ther
Pays: England
ID NLM: 101634502
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
received:
30
12
2022
accepted:
03
02
2023
pubmed:
23
2
2023
medline:
23
2
2023
entrez:
22
2
2023
Statut:
ppublish
Résumé
The purpose of this article was to ascertain the existing literature and find the gaps in economic evaluations of cataracts. Systematic methods were used to search and collect the published literature on economic evaluations of cataracts. A mapping review of studies published in the following bibliographical databases was performed: the National Library of Medicine (PubMed), EMBASE, Web of Science (WOS), and the Central of Reviews and Dissemination (CRD) database. A descriptive analysis was conducted and relevant studies were classified into different groups. Among 984 studies screened, 56 studies were included in the mapping review. Four research questions were answered. There has been a progressive increase of publications during the last decade. The majority of the included studies were published by authors from institutions in the USA and UK. The most commonly investigated area was cataract surgery followed by intraocular lenses (IOLs). The studies were classified into different categories according to the main outcome evaluated, such as comparisons between different surgical techniques, costs of the cataract surgery, second eye cataract surgery costs, quality of life gain after cataract surgery, waiting time of cataract surgery and costs, and cataract evaluation, follow-up, and costs. In the IOL classification, the most frequently studied area was the comparison between monofocal and multifocal IOLs, followed by the comparison between toric and monofocal IOLs. Cataract surgery is a cost-effective procedure compared with other non-ophthalmic and ophthalmic interventions and surgery waiting time is an important factor to consider because vision loss has a huge and broad-ranging impact on society. Numerous gaps and inconsistencies are found among the studies included. For this reason, there is a need for further studies according to the classification described in the mapping review.
Identifiants
pubmed: 36809595
doi: 10.1007/s40123-023-00678-0
pii: 10.1007/s40123-023-00678-0
pmc: PMC10011294
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
789-807Informations de copyright
© 2023. The Author(s).
Références
Burton MJ, Ramke J, Marques AP, et al. The Lancet Global Health Commission on Global Eye Health: vision beyond 2020. Lancet Global Health. 2021;9:e489–551. https://doi.org/10.1016/S2214-109X(20)30488-5 .
doi: 10.1016/S2214-109X(20)30488-5
pubmed: 33607016
Marques AP, Ramke J, Cairns J, et al. Global economic productivity losses from vision impairment and blindness. EClinicalMedicine. 2021;35:100852. https://doi.org/10.1016/J.ECLINM.2021.100852 .
doi: 10.1016/J.ECLINM.2021.100852
pubmed: 33997744
pmcid: 8093883
Assi L, Rosman L, Chamseddine F, et al. Eye health and quality of life: an umbrella review protocol. BMJ Open. 2020;10:e037648. https://doi.org/10.1136/BMJOPEN-2020-037648 .
doi: 10.1136/BMJOPEN-2020-037648
pubmed: 32868362
pmcid: 7462163
Atik A, Barton K, Azuara-Blanco A, Kerr NM. Health economic evaluation in ophthalmology. Br J Ophthalmol. 2021;105:602–7. https://doi.org/10.1136/bjophthalmol-2020-316880 .
doi: 10.1136/bjophthalmol-2020-316880
pubmed: 32829299
Grimes CE, Henry JA, Maraka J, Mkandawire NC, Cotton M. Cost-effectiveness of surgery in low- and middle-income countries: a systematic review. World J Surg. 2014;38:252–63.
doi: 10.1007/s00268-013-2243-y
pubmed: 24101020
Javed Q. Cost-effectivness of surgical interventions in low and middle income countries (LMICs). Int J Surg. 2017;47:S58.
doi: 10.1016/j.ijsu.2017.08.301
Hahn U, Krummenauer F. Results and methodology of cost–utility evaluation of cataract surgery in developed countries: quality-adjusted life years and cataract. J Cataract Refract Surg. 2017;43:839–47.
doi: 10.1016/j.jcrs.2017.05.020
pubmed: 28732620
Gray AM, Clarke PM, Wolstenholme JL, Wordsworth S. Applied methods of cost-effectiveness analysis in health care. 2010. Oxford: OUP; 1386. ISBN 9780199227280.
Gov.UK. Cost effectiveness analysis: health economic studies. https://www.gov.uk/guidance/cost-effectiveness-analysis-health-economic-studies . Accessed 11 Nov 2022.
Gov.UK. Cost utility analysis: health economic studies. https://www.gov.uk/guidance/cost–utility-analysis-health-economic-studies . Accessed 11 Nov 2022.
Gafni A. The standard gamble method: what is being measured and how it is interpreted. Health Serv Res. 1994;29(2):207–24.
pubmed: 8005790
pmcid: 1069999
Dixon P, Hollingworth W, Sparrow J. Mapping to quality of life and capability measures in cataract surgery patients: from Cat-PROM5 to EQ-5D-3L, EQ-5D-5L, and ICECAP-O using mixture modelling. MDM Policy Pract. 2020;5:2381468320915447.
pubmed: 32285008
pmcid: 7137115
Brauer CA, Rosen AB, Greenberg D, Neumann PJ. Trends in the measurement of health utilities in published cost–utility analyses. Value Heal. 2006;9:213–8. https://doi.org/10.1111/J.1524-4733.2006.00116.X .
doi: 10.1111/J.1524-4733.2006.00116.X
Pinto Prades JL, Sánchez Martínez FI. Métodos Para La Evaluación Económica de Nuevas Prestaciones. Madrid: Ministerio de Sanidad y Consumo; 2003.
Brown GC, Brown MM, Chaudhry I, Stein JD. Opportunities to reduce potential bias in ophthalmic cost–utility analysis. JAMA Ophthalmol. 2021;139:389–97. https://doi.org/10.1001/jamaophthalmol.2020.6591 .
doi: 10.1001/jamaophthalmol.2020.6591
pubmed: 33538789
pmcid: 7863010
Torrance GW. Utility approach to measuring health-related quality of life. J Chronic Dis. 1987;40:593–600. https://doi.org/10.1016/0021-9681(87)90019-1 .
doi: 10.1016/0021-9681(87)90019-1
pubmed: 3298297
Brown MM, Brown GC, Sharma S, Kistler J, Brown H. Utility values associated with blindness in an adult population. Br J Ophthalmol. 2001;85:327–31. https://doi.org/10.1136/BJO.85.3.327 .
doi: 10.1136/BJO.85.3.327
pubmed: 11222340
pmcid: 1723892
Brown MM, Brown GC, Sharma S, Hollands H, Landy J. Quality of life and systemic comorbidities in patients with ophthalmic disease. Br J Ophthalmol. 2002;86:8–11. https://doi.org/10.1136/BJO.86.1.8 .
doi: 10.1136/BJO.86.1.8
pubmed: 11801494
pmcid: 1770989
Miake-Lye IM, Hempel S, Shanman R, Shekelle PG. What is an evidence map? A systematic review of published evidence maps and their definitions, methods, and products. 2016. https://doi.org/10.1186/s13643-016-0204-x .
Hetrick SE, Parker AG, Callahan P, Purcell R. Evidence mapping: illustrating an emerging methodology to improve evidence-based practice in youth mental health. J Eval Clin Pract. 2010;16:1025–30.
doi: 10.1111/j.1365-2753.2008.01112.x
pubmed: 20337833
Grant MJ, Booth A. A typology of reviews: an analysis of 14 review types and associated methodologies. Health Info Libr J. 2009;26:91–108.
doi: 10.1111/j.1471-1842.2009.00848.x
pubmed: 19490148
NIHR Centre for Reviews and Dissemination. CRD Database. http://www.crd.york.ac.uk/CRDWeb/ResultsPage.asp . Accessed 11 Sept 2021.
National Institute for Health and Care Excellence. NICE. The Guidelines Manual; 2012; ISBN 978-1-4731-1906-2.
Brown GC, Brown MM, Sharma S, et al. Value-based medicine and ophthalmology: an appraisal of cost–utility analyses. Trans Am Ophthalmol Soc. 2004;102:177.
pubmed: 15747756
pmcid: 1280098
Plüddemann A, Aronson JK, Onakpoya I, Heneghan C, Mahtani KR. Redefining rapid reviews: a flexible framework for restricted systematic reviews. BMJ Evid-Based Med. 2018;23:201–3. https://doi.org/10.1136/bmjebm-2018-110990 .
doi: 10.1136/bmjebm-2018-110990
pubmed: 29950313
Dominski FH, Lorenzetti Branco JH, Buonanno G, Stabile L, da Gameiro Silva M, Andrade A. Effects of air pollution on health: a mapping review of systematic reviews and meta-analyses. Environ Res. 2021;201: 111487. https://doi.org/10.1016/J.ENVRES.2021.111487 .
doi: 10.1016/J.ENVRES.2021.111487
pubmed: 34116013
Fernández-Sotos P, Torio I, Fernández-Caballero A, et al. Social cognition remediation interventions: a systematic mapping review. PLoS ONE. 2018;14:1–20. https://doi.org/10.1371/journal.pone.0218720 .
doi: 10.1371/journal.pone.0218720
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6:e1000100. https://doi.org/10.1371/journal.pmed.1000100 .
doi: 10.1371/journal.pmed.1000100
pubmed: 19621070
pmcid: 2707010
Taylor H, Pezzullo L, Keeffe J. The economic impact and cost of visual impairment in Australia. Br J Ophthalmol. 2006;90(3):272–5.
doi: 10.1136/bjo.2005.080986
pubmed: 16488942
pmcid: 1856946
Rochmah TN, Wulandari A, Dahlui M, Ernawaty, Wulandari RD. Cost effectiveness analysis using disability-adjusted life years for cataract surgery. Int J Environ Res Public Health. 2020;17:6010. https://doi.org/10.3390/ijerph17166010
Kapse R, Agarwal S, Rishikeshi N, et al. Cost analysis of pediatric cataract surgery in a tertiary eye care hospital in Western India. Indian J Ophthalmol. 2022;70:420. https://doi.org/10.4103/ijo.IJO_1229_21 .
doi: 10.4103/ijo.IJO_1229_21
pubmed: 35086208
pmcid: 9023949
Maxwell WA, Waycaster CR, D’Souza AO, Meissner BL, Hileman K. A United States cost-benefit comparison of an apodized, diffractive, presbyopia-correcting, multifocal intraocular lens and a conventional monofocal lens. J Cataract Refract Surg. 2008;34:1855–61. https://doi.org/10.1016/j.jcrs.2008.07.024 .
doi: 10.1016/j.jcrs.2008.07.024
pubmed: 19006730
Weinstein MC, Torrance G, McGuire A. QALYs: the basics. Value Heal. 2009;12:S5–9. https://doi.org/10.1111/j.1524-4733.2009.00515.x .
doi: 10.1111/j.1524-4733.2009.00515.x
Paulden M. Calculating and interpreting ICERs and net benefit. Pharmacoeconomics. 2020;38:785–807. https://doi.org/10.1007/s40273-020-00914-6 .
doi: 10.1007/s40273-020-00914-6
pubmed: 32390067
Asimakis P, Coster DJ, Lewis DJ. Cost effectiveness of cataract surgery: a comparison of conventional extracapsular surgery and phacoemulsification at flinders medical centre. Aust N Z J Ophthalmol. 1996;24:319–25. https://doi.org/10.1111/J.1442-9071.1996.TB01602.X .
doi: 10.1111/J.1442-9071.1996.TB01602.X
pubmed: 8985543
Rizal AM, Aljunid SM, Normalina M, et al. Cost analysis of cataract surgery with intraocular lens implantation: a single blind randomised clinical trial comparing extracapsular cataract extraction and phacoemulsification. Med J Malaysia. 2003;58:380–6.
pubmed: 14750378
Manaf MRA, Aljunid SM, Annuar FH, Leong CK, Mansor N. Cost-effectiveness analysis of cataract surgery with intraocular lens implantation: extracapsular cataract extraction versus phacoemulsification. Med J Indones. 2007;16:25–31.
doi: 10.13181/mji.v16i1.252
Jongsareejit A, Wiriyaluppa C, Kongsap P, Phumipan S. Cost-effectiveness analysis of manual small incision cataract surgery (MSICS) and phacoemulsification (PE). J Med Assoc Thail. 2012;95:212–20.
Abell RG, Vote BJ. Cost-effectiveness of femtosecond laser-assisted cataract surgery versus phacoemulsification cataract surgery. Ophthalmology. 2014;121:10–6.
doi: 10.1016/j.ophtha.2013.07.056
pubmed: 24120324
Khan A, Amitava A, Rizvi SA, Siddiqui Z, Kumari N, Grover S. Cost-effectiveness analysis should continually assess competing health care options especially in high volume environments like cataract surgery. Indian J Ophthalmol. 2015;63:496. https://doi.org/10.4103/0301-4738.162600 .
doi: 10.4103/0301-4738.162600
pubmed: 26265639
pmcid: 4550981
Schweitzer C, Brezin A, Cochener B, et al. Femtosecond laser-assisted versus phacoemulsification cataract surgery (FEMCAT): a multicentre participant-masked randomised superiority and cost-effectiveness trial. Lancet. 2020;395:212–24.
doi: 10.1016/S0140-6736(19)32481-X
pubmed: 31954466
Wulandari A, Dahlui M, Wulandari RD, Rochmah TN. Cost effectiveness analysis between small incision cataract surgery and phacoemulsification. J Heal Transl Med. 2020;23:231–7.
Tuominen R, Immonen I, Raivio I. Economic evaluation of cataract surgery: a comparison between IOL and Non-IOL techniques. Acta Ophthalmol. 1988;66:577–81. https://doi.org/10.1111/j.1755-3768.1988.tb04383.x .
doi: 10.1111/j.1755-3768.1988.tb04383.x
Marseille E. Cost-effectiveness of cataract surgery in a public health eye care programme in Nepal. Bull World Health Organ. 1996;74:319–24.
pubmed: 8789930
pmcid: 2486914
Busbee BG, Brown MM, Brown GC, Sharma S. Incremental cost-effectiveness of initial cataract surgery. Ophthalmology. 2002;109:606–12. https://doi.org/10.1016/S0161-6420(01)00971-X .
doi: 10.1016/S0161-6420(01)00971-X
pubmed: 11874769
Baltussen R, Sylla M, Mariotti SP. Cost-effectiveness analysis of cataract surgery: a global and regional analysis. Bull World Health Organ. 2004;82:338–45.
pubmed: 15298224
pmcid: 2622839
Räsänen P, Krootila K, Sintonen H, et al. Cost-utility of routine cataract surgery. Health Qual Life Outcomes. 2006;4:74. https://doi.org/10.1186/1477-7525-4-74 .
doi: 10.1186/1477-7525-4-74
pubmed: 17010185
pmcid: 1592543
Lansingh VC, Carter MJ, Martens M. Global cost-effectiveness of cataract surgery. Ophthalmology. 2007;114:1670–8.
doi: 10.1016/j.ophtha.2006.12.013
pubmed: 17383730
Sach TH, Foss AJE, Gregson RM, et al. Falls and health status in elderly women following first eye cataract surgery: an economic evaluation conducted alongside a randomised controlled trial. Br J Ophthalmol. 2007;91:1675–9.
doi: 10.1136/bjo.2007.118687
pubmed: 17585002
pmcid: 2095519
Brown GC, Brown MM, Menezes A, Busbee BG, Lieske HB, Lieske PA. Cataract surgery cost utility revisited in 2012. Ophthalmology. 2013;120:2367–76. https://doi.org/10.1016/j.ophtha.2013.04.030 .
doi: 10.1016/j.ophtha.2013.04.030
pubmed: 24246824
Griffiths UK, Bozzani FM, Gheorghe A, Mwenge L, Gilbert C. Cost-effectiveness of eye care services in Zambia. Cost Eff Resour Alloc. 2014;12:6. https://doi.org/10.1186/1478-7547-12-6 .
doi: 10.1186/1478-7547-12-6
pubmed: 24568593
pmcid: 3944959
Boyd M, Kho A, Wilson G, Wilson N. Expediting cataract surgery in New Zealand is cost-effective for falls prevention and improving vision-so what might be the next steps? N Z Med J. 2019;132:73–8.
pubmed: 31465330
Essue BM, Jan S, Phuc HT, Dodson S, Armstrong K, Laba T-L. Who benefits most from extending financial protection for cataract surgery in Vietnam? An extended cost-effectiveness analysis of small incision surgery. Health Policy Plan. 2018;550000:399–407. https://doi.org/10.1093/heapol/czz181 .
doi: 10.1093/heapol/czz181
Busbee BG, Brown MM, Brown GC, Sharma S. Cost-utility analysis of cataract surgery in the second eye. Ophthalmology. 2003;110:2310–7. https://doi.org/10.1016/S0161-6420(03)00796-6 .
doi: 10.1016/S0161-6420(03)00796-6
pubmed: 14644712
Sach TH, Foss AJE, Gregson RM, et al. Second-eye cataract surgery in elderly women: a cost–utility analysis conducted alongside a randomized controlled trial. Eye. 2010;24:276–83. https://doi.org/10.1038/eye.2009.112 .
doi: 10.1038/eye.2009.112
pubmed: 19444295
Frampton G, Harris P, Cooper K, et al. The clinical effectiveness and cost-effectiveness of second-eye cataract surgery: a systematic review and economic evaluation. Health Technol Assess. 2014;18:1–206. https://doi.org/10.3310/hta18680 .
doi: 10.3310/hta18680
pubmed: 25405576
pmcid: 4781176
Cooper K, Shepherd J, Frampton G, Harris P, Lotery A. The cost-effectiveness of second-eye cataract surgery in the UK. Age Ageing. 2015;44:1026–31. https://doi.org/10.1093/ageing/afv126 .
doi: 10.1093/ageing/afv126
pubmed: 26410365
pmcid: 4621232
Kobelt G, Lundström M, Stenevi U. Cost-effectiveness of cataract surgery: method to assess cost-effectiveness using registry data. J Cataract Refract Surg. 2002;28:1742–9. https://doi.org/10.1016/S0886-3350(02)01220-8 .
doi: 10.1016/S0886-3350(02)01220-8
pubmed: 12388022
Naeim A, Keeler EB, Gutierrez PR, Wilson MR, Reuben D, Mangione CM. Is cataract surgery cost-effective among older patients with a low predicted probability for improvement in reported visual functioning? Med Care. 2006;44:982–9. https://doi.org/10.1097/01.mlr.0000228216.18270.3e .
doi: 10.1097/01.mlr.0000228216.18270.3e
pubmed: 17063129
Lansingh VC. Use of global visual acuity data in a time trade-off approach to calculate the cost utility of cataract surgery. Arch Ophthalmol. 2009;127:1183. https://doi.org/10.1001/archophthalmol.2009.113 .
doi: 10.1001/archophthalmol.2009.113
pubmed: 19752429
Hiratsuka Y. Cost-effectiveness of cataract surgery in Japan. Jpn J Ophthalmol. 2011;55:333–42. https://doi.org/10.1007/S10384-011-0041-3/TABLES/9 .
doi: 10.1007/S10384-011-0041-3/TABLES/9
Weale M. A cost-benefit analysis of cataract surgery based on the English longitudinal survey of ageing. J Health Econ. 2011;30:730–9. https://doi.org/10.1016/j.jhealeco.2011.05.008 .
doi: 10.1016/j.jhealeco.2011.05.008
pubmed: 21723632
Hiratsuka Y. Cost-utility analysis of cataract surgery in Japan: a probabilistic Markov modeling study. Jpn J Ophthalmol. 2013;57:391–401. https://doi.org/10.1007/s10384-013-0238-8 .
doi: 10.1007/s10384-013-0238-8
pubmed: 23588297
Moore DB, Slabaugh MA. Surgical outcomes and cost basis for resident-performed cataract surgery in an uninsured patient population. JAMA Ophthalmol. 2013;131:891. https://doi.org/10.1001/jamaophthalmol.2013.202 .
doi: 10.1001/jamaophthalmol.2013.202
pubmed: 24010149
Brown GC, Brown MM, Busbee BG. Cost-utility analysis of cataract surgery in the United States for the year 2018. J Cataract Refract Surg. 2019;45:927–38. https://doi.org/10.1016/j.jcrs.2019.02.006 .
doi: 10.1016/j.jcrs.2019.02.006
pubmed: 31262482
Boyd M, Kvizhinadze G, Kho A, Wilson G, Wilson N. Cataract surgery for falls prevention and improving vision: modelling the health gain, health system costs and cost-effectiveness in a high-income country. Inj Prev. 2020;26:302–9. https://doi.org/10.1136/injuryprev-2019-043184 .
doi: 10.1136/injuryprev-2019-043184
pubmed: 31221667
Hopkins RB, Tarride J-E, Bowen J, et al. Cost-effectiveness of reducing wait times for cataract surgery in Ontario. Can J Ophthalmol. 2008;43:213–7. https://doi.org/10.3129/i08-002 .
doi: 10.3129/i08-002
pubmed: 18347625
Lundström M, Albrecht S, Roos P. Immediate versus delayed sequential bilateral cataract surgery: an analysis of costs and patient value. Acta Ophthalmol. 2009;87:33–8. https://doi.org/10.1111/j.1755-3768.2008.01343.x .
doi: 10.1111/j.1755-3768.2008.01343.x
pubmed: 18786128
Malvankar-Mehta MS, Filek R, Iqbal M, et al. Immediately sequential bilateral cataract surgery: a cost-effective procedure. Can J Ophthalmol. 2013;48:482–8. https://doi.org/10.1016/j.jcjo.2013.05.004 .
doi: 10.1016/j.jcjo.2013.05.004
pubmed: 24314408
Cernat A, Jamieson M, Kavelaars R, et al. Immediate versus delayed sequential bilateral cataract surgery in children: a cost-effectiveness analysis. Br J Ophthalmol. 2022;106:211–7. https://doi.org/10.1136/bjophthalmol-2020-316507 .
doi: 10.1136/bjophthalmol-2020-316507
pubmed: 33218991
Dimock J, Robman LD, McCarty CA, Taylor HR. Cost-effectiveness of digital cataract assessment. Aust N Z J Ophthalmol. 1999;27:208–10. https://doi.org/10.1046/j.1440-1606.1999.00207.x .
doi: 10.1046/j.1440-1606.1999.00207.x
pubmed: 10484193
Jastrzebski A, Villafranca A, Sethi S, Bellan L. Safety and comparative costs of preoperative assessments for cataract surgery: traditional mandatory assessment versus a novel graded assessment system. Can J Anesth. 2016;63:842–50.
doi: 10.1007/s12630-016-0626-x
pubmed: 26943645
Meltzer ME, Congdon N, Kymes SM, et al. Cost and expected visual effect of interventions to improve follow-up after cataract surgery. JAMA Ophthalmol. 2017;135:85. https://doi.org/10.1001/jamaophthalmol.2016.4735 .
doi: 10.1001/jamaophthalmol.2016.4735
pubmed: 27978578
Leung EH, Gibbons A, Koch DD. Cost-effectiveness of preoperative oct in cataract evaluation for multifocal intraocular lens. Ophthalmology. 2020;127:859–65. https://doi.org/10.1016/j.ophtha.2020.01.049 .
doi: 10.1016/j.ophtha.2020.01.049
pubmed: 32173111
Orme ME, Paine AC, Teale CW, Kennedy LM. Cost-effectiveness of the AMOArray multifocal intraocular lens in cataract surgery. J Refract Surg. 2002;18:162–8.
doi: 10.3928/1081-597X-20020301-11
pubmed: 11934206
Lafuma A, Berdeaux G. Modelling lifetime cost consequences of ReSTOR in cataract surgery in four European countries. BMC Ophthalmol. 2008;8:12. https://doi.org/10.1186/1471-2415-8-12 .
doi: 10.1186/1471-2415-8-12
pubmed: 18627594
pmcid: 2488322
De Vries NE, Laurendeau C, Lafuma A, Berdeaux G, Nuijts RMMA. Lifetime costs and effectiveness of ReSTOR compared with a monofocal IOL and Array-SA40 in the Netherlands. Eye. 2010;24:663–72. https://doi.org/10.1038/eye.2009.151 .
doi: 10.1038/eye.2009.151
pubmed: 19575029
Lin J-C, Yang M-C. Cost-effectiveness comparison between monofocal and multifocal intraocular lens implantation for cataract patients in Taiwan. Clin Ther. 2014;36:1422–30. https://doi.org/10.1016/j.clinthera.2014.07.009 .
doi: 10.1016/j.clinthera.2014.07.009
pubmed: 25146366
Hu JQ, Sarkar R, Murphy J, Afshari NA. Cost-effectiveness of multifocal intraocular lenses compared to monofocal intraocular lenses in cataract surgery. Investig Ophthalmol Vis Sci. 2018;59:208–305.
Smith AF, Lafuma A, Berdeaux G, et al. Cost-effectiveness analysis of PMMA, silicone, or acrylic intra-ocular lenses in cataract surgery in four European countries. Ophthalmic Epidemiol. 2005;12:343–51.
doi: 10.1080/09286580500180598
pubmed: 16272054
Pineda R, Denevich S, Lee WC, Waycaster C, Pashos CL. Economic evaluation of toric intraocular lens: a short- and long-term decision analytic model. Arch Ophthalmol. 2010;128:834–40. https://doi.org/10.1001/archophthalmol.2010.127 .
doi: 10.1001/archophthalmol.2010.127
pubmed: 20625042
Kristianslund O, Dalby M, Moe MC, Drolsum L. Cost-effectiveness analysis in a randomized trial of late in-the-bag intraocular lens dislocation surgery: repositioning versus exchange. Acta Ophthalmol. 2019;97:771–7. https://doi.org/10.1111/aos.14108 .
doi: 10.1111/aos.14108
pubmed: 30968572
Simons RWP, Visser N, van den Biggelaar FJHM, et al. Trial-based cost-effectiveness analysis of toric versus monofocal intraocular lenses in cataract patients with bilateral corneal astigmatism in the Netherlands. J Cataract Refract Surg. 2019;45:146–52.
doi: 10.1016/j.jcrs.2018.09.019
pubmed: 30471848
Jain S, Chauhan A, Rajshekar K, et al. Generic and vision related quality of life associated with different types of cataract surgeries and different types of intraocular lens implantation. PLoS ONE. 2020;15:e0240036. https://doi.org/10.1371/journal.pone.0240036 .
doi: 10.1371/journal.pone.0240036
pubmed: 33007038
pmcid: 7531837
Ranno S, Rabbiolo GM, Lucentini S, et al. Angle-supported intraocular lens versus scleral-sutured posterior chamber intraocular lens in post-cataract surgery aphakic patients: two-year follow-up cost-effectiveness analysis. Int Ophthalmol. 2022;42:871–9. https://doi.org/10.1007/s10792-021-02068-6 .
doi: 10.1007/s10792-021-02068-6
pubmed: 34779973
Athanasiov P, Bala C, Holland J, Dhariwal M, Gupta A, Rathi H. A cost-effectiveness analysis of AcrySof IQ vivity intraocular lens from private health fund perspective in Australia. Clin Exp Ophthalmol. 2022;49:878–9.
Laupacis A, Feeny D, Detsky AS, Tugweli PX. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ. 1992;146(4):473–81.
pubmed: 1306034
pmcid: 1488412
Diane C. What is a “mapping study?” J Med Libr Assoc. 2016;104:76–8. https://doi.org/10.3163/1536-5050.104.1.013 .
doi: 10.3163/1536-5050.104.1.013